Pacific Biosciences of California, Inc. Proceeds from Debt, Net of Issuance Costs
Pacific Biosciences of California, Inc. (PACB) reported Proceeds from Debt, Net of Issuance Costs of $19.77 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2016-03-11
- Pacific Biosciences of California, Inc. proceeds from debt, net of issuance costs for the quarter ending 2013-12-31 was $0.00.
- Pacific Biosciences of California, Inc. proceeds from debt, net of issuance costs for the quarter ending 2013-09-30 was $0.00.
- Pacific Biosciences of California, Inc. proceeds from debt, net of issuance costs for the quarter ending 2013-06-30 was $0.00.
- Pacific Biosciences of California, Inc. proceeds from debt, net of issuance costs for the quarter ending 2013-03-31 was $19.77M.
- Pacific Biosciences of California, Inc. proceeds from debt, net of issuance costs for fiscal 2013 was $19.77M.
| Period end | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 6 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $0.00 derived: sum of 2 quarters · filed 2016-03-11 | $0.00 derived: sum of 3 quarters · filed 2016-03-11 | $19.77M 10-K · filed 2016-03-11 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $0.00 derived: sum of 2 quarters · filed 2014-11-05 | $19.77M 10-Q · filed 2014-11-05 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $19.77M 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | $19.77M 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |